- Home
- ZTO vs BDTX Comparison
ZTO vs BDTX Comparison
Compare ZTO & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- BDTX
- Stock Information
- Founded
- ZTO 2002
- BDTX 2014
- Country
- ZTO China
- BDTX United States
- Employees
- ZTO N/A
- BDTX N/A
- Industry
- ZTO Advertising
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZTO Consumer Discretionary
- BDTX Health Care
- Exchange
- ZTO Nasdaq
- BDTX Nasdaq
- Market Cap
- ZTO 13.4B
- BDTX 132.5M
- IPO Year
- ZTO 2016
- BDTX 2020
- Fundamental
- Price
- ZTO $18.83
- BDTX $2.87
- Analyst Decision
- ZTO Buy
- BDTX Strong Buy
- Analyst Count
- ZTO 5
- BDTX 6
- Target Price
- ZTO $22.64
- BDTX $14.83
- AVG Volume (30 Days)
- ZTO 1.3M
- BDTX 1.2M
- Earning Date
- ZTO 08-19-2025
- BDTX 08-05-2025
- Dividend Yield
- ZTO 3.62%
- BDTX N/A
- EPS Growth
- ZTO N/A
- BDTX N/A
- EPS
- ZTO 1.22
- BDTX 0.09
- Revenue
- ZTO $6,230,576,589.00
- BDTX $70,000,000.00
- Revenue This Year
- ZTO $16.57
- BDTX N/A
- Revenue Next Year
- ZTO $12.82
- BDTX N/A
- P/E Ratio
- ZTO $15.83
- BDTX $32.58
- Revenue Growth
- ZTO 14.76
- BDTX N/A
- 52 Week Low
- ZTO $16.34
- BDTX $1.20
- 52 Week High
- ZTO $27.50
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- ZTO 61.20
- BDTX 68.91
- Support Level
- ZTO $17.39
- BDTX $2.43
- Resistance Level
- ZTO $19.42
- BDTX $2.72
- Average True Range (ATR)
- ZTO 0.29
- BDTX 0.18
- MACD
- ZTO 0.16
- BDTX 0.02
- Stochastic Oscillator
- ZTO 74.68
- BDTX 99.31
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.